Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metasta...

Full description

Bibliographic Details
Main Authors: Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L.
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Published: American Association for the Advancement of Science (AAAS) 2018
Online Access:http://hdl.handle.net/1721.1/116976
_version_ 1811002870220193792
author Pattabiraman, D. R.
Bierie, B.
Kober, K. I.
Thiru, P.
Krall, J. A.
Zill, C.
Reinhardt, F.
Tam, W. L.
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Pattabiraman, D. R.
Bierie, B.
Kober, K. I.
Thiru, P.
Krall, J. A.
Zill, C.
Reinhardt, F.
Tam, W. L.
author_sort Pattabiraman, D. R.
collection MIT
description The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intracellular levels of the second messenger, adenosine 3',5'-monophosphate, and the subsequent activation of protein kinase A (PKA) induce a mesenchymal-to-epithelial transition (MET) in mesenchymal human mammary epithelial cells. PKA activation triggers epigenetic reprogramming of TICs by the histone demethylase PHF2, which promotes their differentiation and loss of tumor-initiating ability. This study provides proof-of-principle for inducing an MET as differentiation therapy for TICs and uncovers a role for PKA in enforcing and maintaining the epithelial state.
first_indexed 2024-09-23T15:55:24Z
format Article
id mit-1721.1/116976
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T15:55:24Z
publishDate 2018
publisher American Association for the Advancement of Science (AAAS)
record_format dspace
spelling mit-1721.1/1169762022-09-29T17:05:42Z Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability Pattabiraman, D. R. Bierie, B. Kober, K. I. Thiru, P. Krall, J. A. Zill, C. Reinhardt, F. Tam, W. L. Massachusetts Institute of Technology. Department of Biology Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology) The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intracellular levels of the second messenger, adenosine 3',5'-monophosphate, and the subsequent activation of protein kinase A (PKA) induce a mesenchymal-to-epithelial transition (MET) in mesenchymal human mammary epithelial cells. PKA activation triggers epigenetic reprogramming of TICs by the histone demethylase PHF2, which promotes their differentiation and loss of tumor-initiating ability. This study provides proof-of-principle for inducing an MET as differentiation therapy for TICs and uncovers a role for PKA in enforcing and maintaining the epithelial state. 2018-07-13T15:20:13Z 2018-07-13T15:20:13Z 2016-01 2015-09 2018-07-12T16:36:33Z Article http://purl.org/eprint/type/JournalArticle 0036-8075 1095-9203 http://hdl.handle.net/1721.1/116976 Pattabiraman, D. R. et al. “Activation of PKA Leads to Mesenchymal-to-Epithelial Transition and Loss of Tumor-Initiating Ability.” Science 351, 6277 (March 2016): aad3680 © 2016 American Association for the Advancement of Science http://dx.doi.org/10.1126/SCIENCE.AAD3680 Science Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf American Association for the Advancement of Science (AAAS) PMC
spellingShingle Pattabiraman, D. R.
Bierie, B.
Kober, K. I.
Thiru, P.
Krall, J. A.
Zill, C.
Reinhardt, F.
Tam, W. L.
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title_full Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title_fullStr Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title_full_unstemmed Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title_short Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
title_sort activation of pka leads to mesenchymal to epithelial transition and loss of tumor initiating ability
url http://hdl.handle.net/1721.1/116976
work_keys_str_mv AT pattabiramandr activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT bierieb activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT koberki activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT thirup activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT krallja activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT zillc activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT reinhardtf activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability
AT tamwl activationofpkaleadstomesenchymaltoepithelialtransitionandlossoftumorinitiatingability